GPT Healthcare (GPTHEALTH) Q2 FY27 Profit Jumps 45% as Mature Hospitals Drive Margins
GPT Healthcare's net profit surged 45% YoY in Q2 FY27, driven by higher occupancy and a richer specialty mix, though new hospital losses remain a drag.
GPT Healthcare reported a 45.3% jump in net profit for Q2 FY27, with revenue up 14.1%. The improvement was led by stronger occupancy and a shift to higher-end specialties, expanding margins. The company's expansion plans, however, bring near-term losses.
For GPT Healthcare, the September quarter was a story of its established hospitals hitting their stride. The Eastern India-focused chain delivered a sharp 45% profit jump, showing that its core facilities are now generating strong operating leverage.
The numbers tell a clear story of growth and efficiency. Revenue rose 14.1% year-on-year to ₹135.6 crore, while profit surged to ₹15.4 crore. The net profit margin expanded by 250 basis points to 11.4%, a level not seen in recent quarters.
Revenue & profit
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ2 FY27 | PreviousQ1 FY27 | Same quarter LYQ2 FY26 |
|---|---|---|---|
| Revenue (₹ Cr) | 135.62YoY +14% | 126.20 | 118.91 |
| Profit (₹ Cr) | 15.40YoY +45% | 12.73 | 10.60 |
| Net Profit Margin (%) | 11.4YoY +28% | 10.1 | 8.9 |
The Engine: Occupancy and Specialty Mix
The profit surge was driven by fundamental operational gains. According to the company's earnings call, network occupancy improved to 50.3% from 47.4% a year ago. Excluding the new Raipur facility, occupancy at mature hospitals was a healthy 59.8%.
More importantly, a strategic shift toward higher-end specialties like orthopedics, cardiology, and nephrology boosted realizations. The Average Revenue Per Occupied Bed (ARPOB) grew 7.1% to ₹40,721, as reported by AlphaStreet. This richer case mix allowed profit to grow more than three times faster than revenue.
The Drag: New Hospital Losses
This strong performance comes with a caveat. The newly commissioned Raipur hospital continues to incur significant losses, which management quantified at ₹9 crore for the quarter. Executive Director Anurag Tantia said on the call that breakeven is now expected in Q1 FY28, a slight delay.
Another 155-bed hospital in Jamshedpur is slated to open in early FY28 and is expected to post similar startup losses. These expansion costs are a necessary investment but will weigh on consolidated profitability for the next few quarters.
Guidance and the Road Ahead
Management reaffirmed its full-year guidance, targeting 15-16% revenue growth over FY26. The company also aims for an EBITDA margin around 21%, supported by the mature hospital performance.
The path forward hinges on execution. The core hospital portfolio has demonstrated it can deliver strong margins. The key question is how quickly Raipur can ramp up and how efficiently Jamshedpur is integrated.
Key Points
- GPT Healthcare's Q2 FY27 net profit jumped 45.3% year-on-year to ₹15.4 crore, driven by a 250-basis-point expansion in net profit margin.
- Operational improvements, including higher occupancy and a shift to lucrative specialties, were the primary drivers, with mature hospitals performing strongly.
- Expansion continues with losses from the new Raipur facility (₹9 crore in Q2) and the upcoming Jamshedpur hospital expected to pressure near-term consolidated profits.
- Management remains on track to meet its FY27 guidance of 15-16% revenue growth and an EBITDA margin around 21%.
Hexa Perspective
The quarter confirms the earnings power of GPT Healthcare's established network. The margin expansion from a better specialty mix is a positive, sustainable trend as long as patient volumes hold.
The investment case now balances this proven core performance against the execution risk and cash burn of new hospitals. Investors are effectively funding future growth with current profits, a trade-off that will define returns over the next 18 months.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.
